Jones Soda Co. Reiterates its Focus on Hemp-Derived (HD9) THC Market in Connection with its Recent Divestiture of Its Marijuana-derived THC Product Lines

1. Jones Soda divested its marijuana-derived THC business. 2. Focus remains on hemp-derived THC products, which show sales growth. 3. Retaining HD9 product line expected to enhance core beverage categories. 4. Distribution network includes over 26 top DSD distributors nationally. 5. CEO expresses optimism about strategic priorities post-divestiture.

Corporate Developments

75

7m saved

Insight

Article

FAQ

Why Bullish?

The focus on a growing HD9 product line could enhance revenues, similar to past successful pivots in beverage companies that have focused on trending products.

How important is it?

The divestiture and renewed focus could reposition JSDA favorably in a growing market segment, influencing investor sentiment positively.

Why Short Term?

Immediate sales growth is expected from increased focus on the HD9 line, but market reception will determine longer-term effects.

Related Companies

COKE PEP DPS

SEATTLE, June 26, 2025

/PRNewswire/ -- Jones Soda Co. (CSE: JSDA) (OTCQB: JSDA) ("Jones Soda" or the "Company") a craft beverage company known for its premium sodas and unique consumer engagement, would like to clarify that in connection with the previously announced divestiture of the Company's marijuana-derived THC business, that the Company has retained and continues to focus on its fast growing hemp-derived THC product (HD9) line, which includes Mary Jones sodas, shooters, and gummies, and which has seen four consecutive quarters of sales revenue growth through the first quarter of 2025.